Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLON CANCER, SUSCEPTIBILITY TO
|
1 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.700 | 0 | ||||||||
Breast Carcinoma
|
2793 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.100 | 0.800 | 20 | 2004 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.100 | 0.789 | 19 | 2004 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.050 | 1.000 | 5 | 2007 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.040 | 1.000 | 4 | 2013 | 2017 | |||||
Carcinoma of lung
|
1204 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2007 | 2015 | |||||
Esophageal carcinoma
|
272 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2004 | 2013 | |||||
Esophageal Neoplasms
|
270 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2004 | 2013 | |||||
Malignant neoplasm of esophagus
|
214 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2004 | 2013 | |||||
Malignant neoplasm of lung
|
1142 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2007 | 2015 | |||||
Neoplasms
|
1644 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2006 | 2018 | |||||
Primary malignant neoplasm of lung
|
981 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.030 | 1.000 | 3 | 2007 | 2015 | |||||
Colonic Neoplasms
|
45 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2003 | 2005 | |||||
Colorectal Carcinoma
|
1962 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 0.500 | 2 | 2006 | 2014 | |||||
Lip and Oral Cavity Carcinoma
|
172 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Liver carcinoma
|
942 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 0.500 | 2 | 2006 | 2014 | |||||
Malignant neoplasm of mouth
|
184 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2007 | 2009 | |||||
Malignant neoplasm of stomach
|
615 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2007 | 2009 | |||||
Stomach Carcinoma
|
652 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||
Tumor Progression
|
72 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||
Carcinogenesis
|
355 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.645 | 0.360 | 20 | 56386485 | missense variant | A/C;T | snv | 0.28 | 0.010 | 1.000 | 1 | 2004 | 2004 |